ID: ALA2324165

Max Phase: Preclinical

Molecular Formula: C22H31ClF3N3O3S

Molecular Weight: 510.02

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCCS(=O)(=O)N1CCN(C2(CNC(=O)c3cccc(C(F)(F)F)c3Cl)CCCCC2)CC1

Standard InChI:  InChI=1S/C22H31ClF3N3O3S/c1-2-15-33(31,32)29-13-11-28(12-14-29)21(9-4-3-5-10-21)16-27-20(30)17-7-6-8-18(19(17)23)22(24,25)26/h6-8H,2-5,9-16H2,1H3,(H,27,30)

Standard InChI Key:  VRJAZCJBWPXQIN-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 510.02

Molecular Weight (Monoisotopic): 509.1727

AlogP: 4.15

#Rotatable Bonds: 7

Polar Surface Area: 69.72

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 13.25

CX Basic pKa: 6.55

CX LogP: 3.87

CX LogD: 3.81

Aromatic Rings: 1

Heavy Atoms: 33

QED Weighted: 0.60

Np Likeness Score: -1.63

References

1. Cioffi CL, Wolf MA, Guzzo PR, Sadalapure K, Parthasarathy V, Dethe D, Maeng JH, Carulli E, Loong DT, Fang X, Hu M, Gupta P, Chung M, Bai M, Moore N, Luche M, Khmelnitsky Y, Love PL, Watson MA, Mhyre AJ, Liu S..  (2013)  Design, synthesis, and SAR of N-((1-(4-(propylsulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide inhibitors of glycine transporter-1.,  23  (5): [PMID:23380375] [10.1016/j.bmcl.2013.01.006]

Source

Source(1):

• Scientific Literature